ArticleScientific reports2026
Non-penicillin -susceptible and linezolid-non-susceptible Streptococcus suis clonal complex 233 from humans.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Streptococcus suis is an important swine pathogen and a zoonotic pathogen responsible for systemic diseases in humans. In 2021, an outbreak of non-penicillin-susceptible, optrA-harbouring S. suis serotype 2 sequence type (ST) 1656, belonging to clonal complex 233 (CC233), associated with the consumption of raw pork dishes, was reported in northeastern Thailand. This study aimed to characterize the genetic relationship between non-penicillin-susceptible, optrA-harbouring S. suis CC233 isolates from the outbreak and post-outbreak periods in 2021. We investigated the characteristics of 18 S. suis CC233 strains isolated post-outbreak in 2021 in Thailand using serotyping, multilocus sequence typing, and antimicrobial susceptibility testing. S. suis strains belonging to ST1656 were subjected to whole-genome sequencing. Comparative genome analysis was conducted between the ST1656 outbreak and post-outbreak strains. The analysis revealed that 17 out of 18 strains showed intermediate resistance to penicillin, with three strains exhibiting non-susceptibility to linezolid. PCR serotyping and MLST analysis showed that among the three linezolid-non-susceptible CC233 post-outbreak strains, two were serotype 2 ST1656 and one was serotype 14 ST233. ST1656 post-outbreak strains clustered with ST1656 outbreak strains but formed a separate branch, indicating that the ST1656 outbreak and post-outbreak strains shared the same ancestor. Differences in the genetic organization of the optrA gene, which is associated with linezolid resistance, were observed between outbreak and post-outbreak strains, suggesting that optrA may have been acquired from distinct origins. In contrast, the amino acid sequences of pbp1a, pbp2b, pbp2x, and mraY were identical between the ST1656 outbreak and post-outbreak strains, and their PBP and MraY amino acid sequences were homologous to sequences from non-penicillin-susceptible S. suis ST104 or ST233 strains. These findings highlight the zoonotic risk and emergence of antimicrobial-resistant S. suis CC233, underscoring the need for One Health surveillance and continued monitoring of penicillin and linezolid susceptibility in both swine and human populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.